Simplify Logo

Full-Time

Senior Director

Strategic Product Planning, Rare Disease

Confirmed live in the last 24 hours

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Consulting
Biotechnology

Compensation Overview

$217k - $271.2kAnnually

+ Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

Category
Product Management
Product Strategy
Product
Required Skills
Market Research
Sales
Marketing
Requirements
  • Bachelor’s degree in marketing, health care, business administration or related field; MBA or advanced degree.
  • Targeting 12 years of progressively responsible experience within the pharmaceutical or biotech industry.
  • Requires 5 years’ experience working in rare disease with key internal stakeholders to develop and preparing market for launch.
  • Therapeutic areas such as Neurology, Neuroendocrine, Neuromuscular experience a plus.
  • Recent rare disease pre-launch and launch experience.
  • Requires a solid background in commercialization and applying learnings to strategy and drug development.
  • Strong interpersonal, partnering and cross-functional collaboration skills.
  • Ability to work successfully in a dynamic, fast paced, team-oriented environment with learning agility and style flexibility.
  • Ability to work with leadership and other cross functional peers and colleagues.
  • Proficiency at creating and communicating a clear vision among team members, effectively aligning resources and activities to achieve functional area and/or organizational goals.
  • Ability to challenge the status quo and drive organizational action.
  • Ability to creatively problem solve.
  • Ability to travel up to 30% of time.
Responsibilities
  • Develops the long-range commercial launch plan for the U.S. and other key global markets, including brand growth strategies and tactics that target HCPs, patients & caregivers.
  • Lead commercial strategy for Phase 3 pipeline products, including audience definition and segmentation, value proposition, branding, positioning, and key messaging.
  • Manages productive external relationships with Key Opinion Leaders and Congress leadership.
  • Works with Access & Reimbursement, Medical Affairs and HEOR to develop differentiation, as well as effective strategies and tactics designed to secure appropriate market access for investigational disease products in the portfolio.
  • Manages relationships with key vendors/consultants in support of core HCP/patient/caregiver audience needs and conduct yearly assessments as needed.
  • Assumes overall brand budget accountability and manages promotional spend forecasts; works with finance to monitor spending against budget/forecast; Identifies trends and insights to optimize spend, performance, and ROI.
  • Ensures close collaboration with Patient Services and Patient Advocacy to identify and address key areas of need and to ensure optimal level of engagement and support for the relevant patient and caregiver communities.
  • Develop analysis of target markets to determine current and future treatment paradigms, competitive landscape, unmet need, product positioning and value proposition, making commercial judgements around implications.
  • Drive development of and maintenance of strategic target product profiles (TPPs) for pipeline assets in conjunction with program teams.
  • Provides strategic direction on market research objectives, designs and interpretation to Inform brand strategies.
  • Informs the commercialization plan for potential new assets, particularly as it relates to resource needs and overall market opportunity (i.e. sales force sizing requirements, identification of target patient populations, HCPs, access strategy).
  • Identifies, analyzes, and translates relevant clinical and landscape data, as well as competitive intelligence, to inform the development of asset strategies and BD opportunities.
  • Conducts market/commercial assessment, including forecasts, for BD opportunities with a focus on rare opportunities based on market research, secondary research, and internal subject matter expert collaboration.
  • Assumes program/brand budget accountability for strategic product planning/commercial activities and manages spend forecasts.
  • Other duties as required.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.